The aim of this study was to investigate the effect of the GP IIb/IIIa inhibitor abciximab (ReoPro((R))) on the function and interaction of platelets and leukocytes during experimental CPB.
During cardiac surgery, circulating red blood cells (RBCs) are at risk of exposure to environmental factors during extracorporeal circulation and transfusion of stored RBCs.